|Last Price$33.18||Day Change (%)0.06%|
|Open Price$33.18||Day Change ($)0.02|
|Day Range33.18–33.18||52-Week Range29.63–33.18|
As of Fri 09/22/2017 | USD
A group of top managers remains cautious and commits more capital to traditional defensive sectors, while taking advantage of a rising (and potentially overvalued) market to book some gains.
Four offerings deemed to be right for right now.
Oakmark's investing-centric corporate culture is solid, but lower fees would be welcome.
We saw a higher level of trading by our top managers in the most recent period.
Our top managers could look beyond pharmaceuticals for additional yield.
Each option, including owning no world-stock funds at all, has its pros and cons.